Inquiry Basket
Payload-Based Drug Delivery Solution Selection
Drug Delivery Payload Solutions
BOC Sciences provides payload-based drug delivery solution development services for small molecules, peptides, proteins, antibodies, DNA, RNA, aptamers, enzymes, vaccine-related payloads, and viral vectors. We help clients match payload properties with polymer carrier systems, loading strategies, release profiles, formulation characterization, and optimization pathways.
Payload-Guided Delivery Strategy Support
We help route molecule-specific delivery projects from payload properties to suitable polymer carrier formats, loading methods, release testing, and characterization plans.
- Payload type, molecular size, charge, solubility, and stability review
- Polymer carrier strategy selection based on molecule properties
- Loading, encapsulation, conjugation, surface presentation, and release design
- Characterization planning and formulation optimization guidance
Why Drug Delivery Strategy Should Start with the Payload
Drug delivery development should begin with the molecule being delivered. A small hydrophobic compound, a charged peptide, a folded protein, an antibody, a plasmid DNA, an RNA payload, an aptamer, an enzyme, an antigen, and a viral vector do not require the same carrier design logic. Each molecule type has different risks related to solubility, degradation, aggregation, electrostatic interaction, steric accessibility, activity retention, release rate, and formulation stability.
BOC Sciences supports molecule-based drug delivery solution development by connecting payload properties with polymer nanoparticles, micelles, hydrogels, nanogels, microcapsules, polymer conjugates, polyplex-like systems, surface-functionalized carriers, and hybrid delivery formats. This page helps clients identify the most relevant downstream service route before starting detailed formulation development.
Payload Properties Define Carrier Requirements
Different molecules require different carrier environments. Hydrophobic small molecules may need solubilizing cores, nucleic acids may require charge-based complexation and protection, proteins and enzymes may need mild hydrated matrices, and viral vectors may require compatibility-focused polymer environments.
Loading Method Depends on Molecular Behavior
Payloads may be loaded by physical encapsulation, hydrophobic partitioning, electrostatic assembly, adsorption, covalent conjugation, surface coupling, hydrogel embedding, microcapsule retention, or affinity-assisted immobilization. Method choice should follow molecule stability and release needs.
Characterization Must Match the Payload
Useful characterization endpoints vary by molecule type. Small molecules may require loading and release assays, proteins may require structural and activity-related evaluation, nucleic acids require integrity and complexation analysis, and viral vectors require retention, aggregation, and matrix compatibility assessment.
Common Challenges in Payload-Based Drug Delivery Development
Drug delivery failure often results from a mismatch between payload properties and carrier design. A carrier that improves solubility for one molecule may destabilize a protein, over-complex a nucleic acid, restrict enzyme activity, reduce antibody accessibility, or cause viral vector aggregation. Therefore, molecule-based delivery development should evaluate molecular size, charge, hydrophilicity, conformation, sensitivity, loading route, release conditions, and analytical feasibility together.
Poor Solubility or Low Loading
Hydrophobic molecules, peptides, and some biologics may show low loading when the polymer core, solvent system, carrier polarity, or matrix structure is not compatible.
Payload Instability During Formulation
Proteins, antibodies, enzymes, RNA, DNA, vaccine-related payloads, and viral vectors may be affected by pH, solvent, shear, ionic strength, interfaces, or storage conditions.
Burst Release or Excessive Retention
Weak payload-carrier interaction may cause rapid leakage, while overly strong interaction may prevent useful release, reduce activity, or limit functional accessibility.
Charge and Surface Interaction Problems
Cationic, anionic, or zwitterionic molecules can interact strongly with polymers, surfactants, coatings, or networks, causing aggregation, overbinding, or poor reproducibility.
Difficulty Matching Payload and Platform
Clients may know the molecule but not whether nanoparticles, micelles, hydrogels, nanogels, microcapsules, conjugates, or hybrid systems are most appropriate.
Incomplete Analytical Strategy
Without payload-specific assays, loading measurement, release testing, stability evaluation, and carrier characterization, it is difficult to determine whether a formulation meets project goals.
Payload-Based Drug Delivery Solution Portfolio
BOC Sciences organizes drug delivery services around the molecule being delivered, because payload type strongly influences carrier selection, loading route, stability strategy, release profile, and characterization endpoints. This portfolio connects clients to the most relevant downstream delivery solution pages, including small molecules, peptides, proteins, antibodies, DNA, RNA, aptamers, enzymes, vaccine-related payloads, and viral vectors. Each solution can be further customized with polymer nanoparticles, micelles, hydrogels, nanogels, microcapsules, conjugates, surface-functionalized carriers, and hybrid systems.
Small-Molecule Drug Delivery Solutions
For hydrophobic, poorly soluble, labile, or release-sensitive small-molecule payloads requiring polymeric solubilization, encapsulation, micelle formulation, nanoparticle loading, hydrogel incorporation, or controlled release design.
- Small-molecule-loaded polymer nanoparticles, micelles, hydrogels, nanogels, and microcapsules
- Solubility improvement, loading optimization, and burst release control
- Hydrophobic core design, degradable matrix design, and release profile tuning
- Loading efficiency, release testing, particle characterization, and stability evaluation
Peptide Drug Delivery Solutions
For peptide payloads requiring protection from degradation, improved retention, surface presentation, conjugation, hydrogel embedding, nanoparticle formulation, or sustained release.
- Peptide-loaded nanoparticles, hydrogels, nanogels, microcapsules, and conjugates
- Peptide stability, charge interaction, and diffusion control
- Surface-functionalized polymer carriers and spacer design
- Peptide loading, leakage, release, and formulation stability evaluation
Protein Drug Delivery Solutions
For folded protein payloads requiring mild formulation, conformational protection, hydration control, aggregation reduction, release testing, and activity- or structure-related characterization.
- Protein-loaded polymer nanoparticles, hydrogels, nanogels, and microcapsules
- PEG-based, polysaccharide-based, and hydrogel-forming carrier design
- Protein aggregation, leakage, and release profile control
- Protein loading, stability, structural integrity, and activity-related evaluation
Antibody Drug Delivery Solutions
For antibody, antibody fragment, or antibody-associated payloads requiring polymer carrier protection, surface orientation, conjugation, hydrogel retention, microcapsule formulation, or stability-focused delivery design.
- Antibody-loaded hydrogels, nanoparticles, nanogels, and microcapsules
- Antibody-polymer conjugation and surface presentation strategy
- Aggregation control, binding accessibility, and formulation compatibility
- Loading, release, stability, morphology, and surface characterization
DNA Drug Delivery Solutions
For plasmid DNA, linear DNA, oligonucleotide, or DNA-based research payloads requiring polymer condensation, protection, nanoparticle formulation, DNA-polymer conjugation, or release optimization.
- DNA polyplex platforms, polymeric DNA nanoparticles, and hybrid carriers
- Cationic polymer, biodegradable polymer, PEGylated polymer, and dendrimer-based design
- DNA loading, complexation, integrity, protection, and release evaluation
- DNA-polymer conjugation and formulation troubleshooting
RNA Drug Delivery Solutions
For mRNA, siRNA, saRNA, miRNA, ASO, or other RNA payloads requiring polymer carrier protection, complexation, hybrid formulation, RNA integrity preservation, and release evaluation.
- RNA polyplexes, polymeric RNA nanoparticles, polymer-lipid hybrids, nanogels, and conjugates
- Ionizable or cationic polymer carrier screening
- RNA loading, integrity, protection, release, and storage stability evaluation
- Formulation optimization for charge balance and colloidal stability
Aptamer Drug Delivery Solutions
For aptamer-guided delivery systems requiring aptamer-polymer conjugation, surface-functionalized carriers, aptamer-modified nanoparticles, micelles, hydrogels, nanogels, or responsive polymer systems.
- Aptamer-modified polymer nanoparticles, micelles, nanogels, and hydrogels
- Aptamer-polymer conjugates and surface coupling strategy
- Ligand density, binding accessibility, spacer, and orientation control
- Payload loading, release, aptamer functionalization, and carrier characterization
Enzyme Drug Delivery Solutions
For enzyme payloads requiring activity-preserving polymer carriers, hydrated matrices, enzyme-loaded microcapsules, nanogels, hydrogels, enzyme-polymer conjugates, or sustained release.
- Enzyme-loaded nanoparticles, hydrogels, nanogels, and polymer microcapsules
- Enzyme-polymer conjugation and functional polymer carrier design
- Activity retention, substrate accessibility, leakage, and release evaluation
- Carrier microenvironment and stability optimization
Vaccine Delivery Solutions
For antigen, antigen-adjuvant, DNA vaccine, RNA vaccine, protein antigen, peptide antigen, polysaccharide antigen, tumor antigen research payloads, virus-like particle-associated antigens, adjuvant molecules, or immunostimulatory molecules requiring polymer carrier design.
- Antigen-loaded nanoparticles, microspheres, microcapsules, hydrogels, and nanogels
- Antigen-adjuvant co-delivery and surface-displayed antigen carrier design
- DNA/RNA vaccine research payload carrier strategy
- Loading, release, antigen stability, co-loading, and carrier characterization
Viral Vector Delivery Solutions
For AAV, adenoviral vector, lentiviral vector, retroviral-like vector, VSV-like vector, baculoviral vector, or related research-stage viral vector systems requiring polymer-assisted stabilization, retention, release, coating, hydrogel loading, or microcapsule formulation.
- Viral vector-loaded hydrogels, polymer microcapsules, protective matrices, and scaffold-like carriers
- Polymer-coated or vector-associated polymer systems
- Vector retention, leakage, aggregation, release, and matrix compatibility evaluation
- Carrier characterization and formulation optimization
Not Sure Which Delivery Route Fits Your Molecule?
Share the molecule type, solubility, stability concern, loading goal, and release objective. We can help route your project to the most relevant molecule-specific delivery strategy.
Polymer Carrier Strategies Across Drug Delivery Molecules
Different molecule types can require different polymer carrier architectures, but many projects use a shared set of formulation building blocks. Polymer nanoparticles, micelles, hydrogels, nanogels, microcapsules, conjugates, and surface-functionalized carriers can be selected or combined depending on payload solubility, charge, stability, release target, and analytical requirements. BOC Sciences applies these polymer carrier capabilities to help clients translate payload-specific requirements into practical formulation strategies, carrier design options, and characterization plans.
Polymeric Nanoparticles
Polymeric nanoparticles can support small molecules, peptides, proteins, DNA, RNA, antigens, and selected vector-associated systems through encapsulation, surface coating, charge-based loading, controlled release, and carrier characterization.
- Payload encapsulation, adsorption, coating, or core-shell loading
- Particle size, PDI, zeta potential, and morphology control
- Biodegradable polymer, PEGylated polymer, and functional polymer design
- Loading, release, stability, and colloidal behavior evaluation
Polymer Micelles
Polymer micelles are useful for hydrophobic small molecules, selected peptides, aptamer-guided payload systems, and amphiphilic polymer carrier projects where solubilization, core loading, particle size control, and release tuning are important.
- Hydrophobic core formation and payload partitioning
- Amphiphilic block copolymer selection
- Micelle size, stability, and release profile adjustment
- Compatibility with PEG shielding or ligand-functionalized carriers
Polymer Hydrogels
Polymer hydrogels can support proteins, enzymes, antigens, viral vectors, peptides, and sustained release payloads by providing a hydrated matrix, local retention, diffusion control, and a soft polymer environment.
- PEG, alginate, chitosan, gelatin, PVA, and polysaccharide hydrogel design
- Mesh size, swelling, crosslinking density, and release control
- Payload retention, leakage, stability, and diffusion evaluation
- Soft matrix design for sensitive biological payloads
Polymer Microcapsules
Polymer microcapsules can support sensitive or release-controlled payloads through core-shell protection, semi-permeable barriers, compartmentalized retention, and leakage control. They are useful for peptides, proteins, enzymes, antigens, viral vectors, and other payloads requiring a protected polymer microenvironment.
- Core-shell, hollow capsule, multilayer, or semi-permeable shell design
- Capsule size, shell thickness, permeability, and matrix compatibility adjustment
- Payload retention, leakage, diffusion, and controlled release evaluation
- Compatibility with natural polymers, biodegradable polymers, and functional coatings
Polymer Microspheres
Polymer microspheres are suitable for microscale payload loading, depot-like release, degradable matrix design, and sustained delivery studies. They can be used for small molecules, peptides, antigens, enzymes, and other payloads that benefit from controlled particle size, porosity, and degradation behavior.
- Microsphere formulation using biodegradable, natural, or functional polymers
- Particle size distribution, porosity, morphology, and degradation control
- Payload loading, burst release, sustained release, and stability evaluation
- Carrier design for depot-like release and microscale formulation comparison
Polymer Conjugates and Bioconjugation
Polymer conjugation and bioconjugation strategies can be used for proteins, antibodies, aptamers, enzymes, peptides, DNA/RNA-related systems, and surface-functionalized carriers where linker design, spacing, orientation, and accessibility are important.
- Covalent coupling, spacer selection, and linker chemistry planning
- Polymer-payload conjugation and surface functionalization
- Conjugation verification and purification strategy
- Accessibility, activity, binding, or release-related evaluation where applicable
Drug Delivery Strategy Selection by Molecule Type
Molecule type is one of the most important factors in drug delivery design. Payload molecular weight, charge, hydrophobicity, conformation, degradation sensitivity, activity requirement, and analytical method availability all influence whether the project should begin with nanoparticles, micelles, hydrogels, microcapsules, conjugates, polyplex-like systems, surface-functionalized carriers, or protective polymer matrices. The following table provides a practical selection framework for routing projects into the right downstream service page.
| Molecule Type | Key Delivery Challenge | Recommended Polymer Strategy | Best-Fit Service Page |
|---|---|---|---|
| Small molecules | Poor solubility, crystallization, burst release, low loading | Polymeric micelles, nanoparticles, hydrogels, degradable matrices | Small-Molecule Drug Delivery Solutions |
| Peptides | Enzymatic degradation, rapid diffusion, charge interaction, low retention | Nanoparticles, hydrogels, microcapsules, conjugates, surface-functionalized carriers | Peptide Drug Delivery Solutions |
| Proteins | Aggregation, structural instability, activity loss, harsh formulation stress | Hydrated matrices, nanogels, hydrogels, microcapsules, PEG-based carriers | Protein Drug Delivery Solutions |
| Antibodies | Aggregation, binding accessibility, orientation, large molecular size | Hydrogels, nanogels, polymer conjugates, surface-stabilized carriers | Antibody Drug Delivery Solutions |
| DNA | Negative charge, nuclease sensitivity, complexation, release balance | Cationic polymers, polyplexes, polymer nanoparticles, conjugates, hybrid carriers | DNA Drug Delivery Solutions |
| RNA | Hydrolysis sensitivity, charge balance, integrity loss, storage instability | Ionizable/cationic polymers, nanogels, polymer-lipid hybrids, PEG-shielded systems | RNA Drug Delivery Solutions |
| Aptamers | Folding retention, surface accessibility, nuclease sensitivity, conjugation control | Aptamer-polymer conjugates, surface-functionalized nanoparticles, hydrogels, micelles | Aptamer Drug Delivery Solutions |
| Enzymes | Activity retention, substrate accessibility, leakage, aggregation | Hydrogels, nanogels, microcapsules, enzyme-polymer conjugates | Enzyme Drug Delivery Solutions |
| Vaccine-related payloads | Antigen stability, co-delivery, surface presentation, controlled release | Antigen-loaded particles, hydrogels, microcapsules, co-delivery carriers | Vaccine Delivery Solutions |
| Viral vectors | Capsid/envelope sensitivity, aggregation, matrix compatibility, retention-release balance | Vector-loaded hydrogels, microcapsules, protective matrices, polymer coatings | Viral Vector Delivery Solutions |
How We Support Molecule-Based Drug Delivery Development
BOC Sciences supports molecule-based drug delivery development from payload property review and carrier strategy selection through formulation design, loading or conjugation, release testing, characterization, and optimization planning. Projects can begin from a clearly defined molecule type or from a delivery challenge such as poor solubility, instability, low loading, aggregation, rapid leakage, activity loss, nucleic acid degradation, or vector-carrier incompatibility.
Payload and Project Feasibility Assessment
We review payload identity, molecular behavior, available sample information, and project goals to determine the most relevant delivery route.
- Molecule type, molecular size, charge, solubility, stability, and sample amount review
- Payload sensitivity to pH, solvent, ionic strength, shear, temperature, enzymatic degradation, or interfacial stress
- Loading goal, release objective, assay availability, and carrier preference assessment
- Recommendation of the most relevant molecule-specific service route
Carrier Format and Material Selection
Carrier and material selection connect molecule properties with polymer architecture, loading method, and release objective.
- Nanoparticle, micelle, hydrogel, nanogel, microcapsule, conjugate, polyplex-like, or hybrid carrier selection
- Polymer hydrophilicity, degradability, charge, matrix density, and functional group planning
- Matching of carrier microenvironment to molecule-specific stability requirements
- Initial material and formulation strategy proposal
Loading, Encapsulation, Complexation or Conjugation Design
Loading strategy is selected according to payload solubility, charge, structure sensitivity, functional accessibility, and release requirements.
- Encapsulation, adsorption, hydrophobic loading, electrostatic complexation, covalent conjugation, surface coupling, or matrix embedding strategy
- Linker, spacer, coating, charge ratio, polymer ratio, or crosslinking condition planning
- Mild processing condition design for sensitive biologics, nucleic acids, enzymes, antibodies, and vectors
- Loading efficiency, leakage, accessibility, or retention evaluation plan
Release Testing and Stability Evaluation
Release and stability studies help determine whether the selected carrier improves delivery behavior without compromising payload quality.
- Release profile, burst release, leakage, degradation, matrix swelling, or retention analysis
- Payload integrity, activity-related readout, aggregation, or structural stability evaluation where applicable
- Carrier stability under storage or release conditions
- Comparison of formulation options by molecule-specific criteria
Carrier Characterization and Analytical Planning
Characterization plans are matched to molecule type, carrier format, loading method, and key decision points.
- Size, PDI, zeta potential, morphology, surface behavior, matrix swelling, degradation, and permeability evaluation
- Loading and release assay planning based on payload chemistry
- Surface density, conjugation verification, complexation analysis, or activity-related endpoints where relevant
- Data interpretation to support formulation decisions
Formulation Troubleshooting and Optimization
Troubleshooting identifies whether formulation failure originates from molecule properties, carrier design, preparation conditions, or analytical mismatch.
- Low loading, poor solubility, aggregation, leakage, activity loss, nucleic acid instability, excessive retention, or release mismatch analysis
- Polymer material, carrier architecture, charge ratio, coating, crosslinking, linker, and process condition adjustment
- Identification of whether failure originates from payload properties, carrier design, preparation method, or analytical mismatch
- Next-stage optimization recommendations
Molecule-Based Drug Delivery Development Workflow
Our workflow is designed to help clients move from an identified molecule to a technically appropriate delivery strategy. Each stage evaluates how payload properties, polymer carrier architecture, loading route, release profile, and characterization data should be connected. The workflow can be adapted for small molecules, peptides, proteins, antibodies, DNA, RNA, aptamers, enzymes, vaccine-related payloads, and viral vectors.
Payload Requirement Review
We begin by collecting molecule type, molecular weight, charge, solubility, stability information, buffer or solvent condition, available sample amount, assay availability, delivery objective, release goal, and existing formulation issues. This stage clarifies whether the project is primarily limited by solubility, loading, degradation, aggregation, leakage, activity retention, nucleic acid integrity, or carrier compatibility.
Molecule-Specific Risk Assessment
The payload is assessed according to molecular size, hydrophobicity, charge, conformation, sensitivity to processing conditions, and available analytical methods. We identify whether the main risk is poor solubility, aggregation, enzymatic degradation, activity loss, nuclease sensitivity, charge overbinding, burst release, surface accessibility, matrix incompatibility, or a mismatch between payload and carrier format.
Downstream Service Route Selection
Based on the payload type, the project is routed toward Small-Molecule, Peptide, Protein, Antibody, DNA, RNA, Aptamer, Enzyme, Vaccine, or Viral Vector Delivery Solutions. Some projects may require combined support, such as polymer conjugation plus nanoparticle formulation, hydrogel retention plus release testing, or nucleic acid complexation plus surface stabilization.
Polymer Carrier Strategy Shortlisting
Candidate carrier formats are compared, including nanoparticles, micelles, hydrogels, nanogels, microcapsules, microspheres, conjugates, polyplex-like systems, surface-modified carriers, and hybrid systems. Each option is reviewed against payload solubility, charge, structural sensitivity, loading route, release duration, sample availability, and characterization feasibility before selecting a practical development path.
Material and Formulation Design
Polymer classes such as biodegradable polymers, PEGs and derivatives, natural polymers and derivatives, amine-functional polymers, hydrogel polymers, responsive polymers, or dendrimer-like structures are selected. The formulation plan defines loading, encapsulation, complexation, conjugation, surface coating, matrix embedding, or release-control strategy.
Prototype Formulation and Characterization
Prototype delivery systems are prepared and characterized according to the selected molecule-carrier strategy. Typical evaluation may include size, PDI, zeta potential, morphology, loading efficiency, surface density, complexation, conjugation verification, swelling, permeability, release profile, and payload-specific stability or activity-related assessment where applicable to the project.
Data Review and Carrier Optimization
Formulation data are reviewed to determine whether loading, release, stability, aggregation, activity, integrity, leakage, or retention meets the development objective. Optimization may adjust polymer material, carrier architecture, process condition, charge ratio, coating, crosslinking, matrix density, linker design, or release testing condition to improve molecule-carrier compatibility.
Delivery Strategy Report and Next-Step Recommendation
The project concludes with a molecule-based delivery strategy summary, carrier design rationale, formulation data interpretation, key risk points, recommended downstream service route, and follow-up testing suggestions. This output helps clients decide whether to continue with payload-specific formulation optimization, carrier comparison, release evaluation, conjugation development, or scale-appropriate prototype refinement.
Deliverables for Drug Delivery Molecule Projects
Deliverables are customized according to molecule type, project stage, sample availability, and formulation objectives. A molecule-based drug delivery project may produce a service route recommendation, carrier strategy report, prototype formulation, loading and release data, stability observations, carrier characterization results, and optimization recommendations. The goal is to provide a practical bridge from payload properties to a testable delivery system.
Molecule-Based Delivery Strategy Report
Summarizes payload type, molecular properties, key risks, recommended carrier formats, downstream service route, and formulation development priorities.
Polymer Carrier Design Rationale
Explains how polymer category, carrier architecture, loading method, surface chemistry, matrix behavior, and release strategy match the payload.
Prototype Delivery Formulations
May include nanoparticles, micelles, hydrogels, nanogels, microcapsules, conjugates, polyplex-like systems, or hybrid carriers.
Loading, Release and Stability Data
Includes loading efficiency, encapsulation behavior, release profile, leakage, burst release, storage stability, payload integrity, or activity-related observations.
Carrier Characterization Data
Provides size, PDI, zeta potential, morphology, surface behavior, swelling, degradation, permeability, complexation, or conjugation verification.
Optimization and Routing Recommendation
Suggests downstream service route, material screening direction, process adjustment, characterization method, and formulation optimization strategy.
Why Choose BOC Sciences for Drug Delivery Solutions
BOC Sciences combines polymer chemistry, polymer synthesis, custom polymer modification, polymer bioconjugation services, nanocarrier formulation, hydrogel design, microcapsule development, and polymer characterization services to support molecule-based drug delivery projects. Instead of applying one carrier format to every molecule, the service begins with payload behavior and then selects a formulation strategy based on solubility, stability, charge, size, structure, release objective, and available analytical endpoints.
Molecule-First Service Logic
Development starts from payload type and molecular properties rather than applying one platform to every project.
Coverage Across Major Payload Types
Projects can cover small molecules, peptides, proteins, antibodies, DNA, RNA, aptamers, enzymes, vaccine-related payloads, and viral vectors.
Integrated Polymer Carrier Options
Carrier options include nanoparticles, micelles, hydrogels, nanogels, microcapsules, microspheres, polymer conjugates, surface-functionalized carriers, and hybrid systems.
Payload-Specific Characterization Planning
Characterization may include loading, release, stability, integrity, activity-related readouts, complexation, surface density, swelling, permeability, and aggregation assessment.
Customizable Development Scope
Projects may begin from feasibility assessment, carrier comparison, prototype formulation, loading evaluation, release testing, troubleshooting, or downstream solution development.
Clear Internal Service Pathway
This page functions as a molecule delivery hub, connecting payload-specific solution pages with polymer technology services and material selection routes.
Frequently Asked Questions
These questions address common decision points for molecule-based drug delivery projects, including payload type, platform selection, sample information, carrier formats, characterization requirements, and routing to more specific downstream services.
What are drug delivery molecule solutions?
Drug delivery molecule solutions are services organized around the type of payload being delivered. Instead of selecting one platform first, the process evaluates small molecules, peptides, proteins, antibodies, DNA, RNA, aptamers, enzymes, vaccine-related payloads, or viral vectors and then matches each molecule with suitable polymer carriers, loading strategies, and characterization methods.
How do I choose the right drug delivery solution for my molecule?
The best route depends on molecular weight, charge, solubility, hydrophobicity, stability sensitivity, release objective, assay availability, and preferred carrier format. A hydrophobic small molecule may need micelles, while RNA may need protective complexation. Protein, enzyme, antibody, antigen, and vector payloads often require milder hydrated carrier environments.
What information is needed before starting a molecule-based delivery project?
Useful starting information includes molecule type, purity or composition, molecular weight, charge, solubility, buffer or solvent condition, available sample amount, stability data, loading goal, release goal, assay method, and current formulation problem. These details help determine carrier format, material selection, loading route, and characterization priorities.
Can one polymer platform work for all drug molecules?
A single polymer platform is usually not appropriate for all payloads. Molecules differ in solubility, charge, structure, activity requirements, degradation sensitivity, release behavior, and analytical methods. A platform that improves small-molecule solubility may destabilize proteins, overbind nucleic acids, reduce enzyme activity, or aggregate viral vectors.
Which molecules are suitable for polymer-based delivery?
Polymer-based delivery can be considered for small molecules, peptides, proteins, antibodies, nucleic acids, aptamers, enzymes, antigens, adjuvant molecules, immunostimulatory molecules, and viral vectors. Suitability depends on the molecule's stability, desired loading route, carrier compatibility, release objective, and whether reliable analytical methods are available for evaluation.
What carrier formats can be considered?
Carrier formats may include polymeric nanoparticles, micelles, hydrogels, nanogels, microcapsules, microspheres, polymer conjugates, polyplex-like systems, surface-functionalized carriers, and hybrid systems. The choice depends on whether the project needs solubility improvement, nucleic acid protection, activity retention, surface presentation, co-delivery, controlled release, or local matrix retention.
How are molecule delivery formulations characterized?
Characterization is matched to the payload and carrier format. Common tests may include loading efficiency, release profile, particle size, PDI, zeta potential, morphology, stability, integrity, activity-related readouts, surface density, complexation, conjugation verification, swelling, permeability, degradation, leakage, retention, or aggregation analysis.
Can this page help route my project to a more specific service?
Yes. This page functions as a selection hub for molecule-specific delivery services. Once the payload type and main formulation challenge are identified, the project can be routed to Small-Molecule, Peptide, Protein, Antibody, DNA, RNA, Aptamer, Enzyme, Vaccine, or Viral Vector Delivery Solutions for more focused development.
Submit Your Drug Delivery Project Inquiry
Please share your molecule type, molecular weight, charge or composition, solubility information, buffer or solvent condition, stability concerns, available sample amount, preferred carrier format, loading goal, release objective, and current formulation challenge. Our team can help identify a molecule-based drug delivery development strategy and recommend the most suitable downstream service route.
- Small molecule, peptide, protein, antibody, DNA, RNA, aptamer, enzyme, vaccine-related, and viral vector payloads
- Nanoparticles, micelles, hydrogels, nanogels, microcapsules, conjugates, polyplex-like systems, and hybrid carriers
- Payload loading, release testing, stability evaluation, carrier characterization, and formulation optimization
- Downstream service routing based on molecule type and delivery challenge
